Jason Throne, VP, General Counsel at IDEAYA Biosciences, Inc. (IDYA), sold 2,205 shares at $8.66 ($19K) on 2020-06-04, disclosed to the SEC on 2020-06-08.
Scheduled sale ($19k) by VP, General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| Filing → |
| IDYA | SELL | 2023-09-14 | $30K | — | Filing → |
| IDYA | SELL | 2023-09-06 | $167K | — | Filing → |
| IDYA | SELL | 2023-08-11 | $125K | — | Filing → |